Northwest Biotherapeutics: Q1 Earnings Snapshot

Published: 2026-05-15 17:12:21 ET NWBO

Published on 05/15/2026 at 05:12 pm EDT

BETHESDA, Md. (AP) — BETHESDA, Md. (AP) — Northwest Biotherapeutics Inc. (NWBO) on Friday reported a loss of $3.1 million in its first quarter.

On a per-share basis, the Bethesda, Maryland-based company said it had a loss of less than 1 cent.

The cancer drug developer posted revenue of $494,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NWBO at https://www.zacks.com/ap/NWBO

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News